Stoke Therapeutics, Inc. · NASDAQ:STOK
Ticho Barry sold 7,176 Stoke Therapeutics, Inc. shares (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Ticho Barry (CHIEF MEDICAL OFFICER) sold 7,176 Stoke Therapeutics, Inc. shares at an average US$29.04 for US$208K under a trading plan, leaving 20,422 shares. Filed Aug 5, 2026 (Form 4).
- Sold
- 7,176 shares
- Price
- US$29.04 average (US$28.95 to US$29.45)
- Value
- US$208K
- Holding after
- 20,422 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- CHIEF MEDICAL OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Sale | 5,907 | US$28.95 | 21,691 | Direct |
| Aug 3, 2026 | Common Stock | Sale | 1,269 | US$29.45 | 20,422 | Direct |
Source
Related
- Stoke Therapeutics, Inc.
- Ticho Barry
- Stoke Therapeutics, Inc. shareholders
- Form 4 · Ticho Barry · Oct 2, 2026
- Form 4 · Ticho Barry · Sep 3, 2026
- Form 4 · Ticho Barry · Aug 18, 2026
- Form 4 · Ticho Barry · Jul 6, 2026
- Form 4 · Ticho Barry · Jun 3, 2026
- Form 4 · Allan Jonathan · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Sep 30, 2026
- Form 4 · Kaye Edward M. MD · Aug 18, 2026
- Form 4 · Allan Jonathan · Aug 18, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026